Cryo-Cell International, Inc. CCEL
AMEX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 129.08% | 1,077.49% | 101.23% | -609.39% | 110.62% |
| Total Depreciation and Amortization | -2.94% | 0.44% | 3.57% | -6.62% | 2.70% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | -1.92% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 31.40% | -48.77% | -67.31% | 190.48% | 14.67% |
| Change in Net Operating Assets | -239.83% | 277.28% | -112.28% | 268.76% | 239.75% |
| Cash from Operations | -38.14% | 183.20% | -49.11% | -49.51% | 258.80% |
| Capital Expenditure | -211.62% | 51.27% | 0.15% | -73.20% | 37.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -216.54% | -21.46% | 138.76% | -119.45% | 173.51% |
| Cash from Investing | -616.57% | 83.25% | 106.60% | -126.22% | 173.50% |
| Total Debt Issued | -- | -100.00% | -40.00% | -- | -100.00% |
| Total Debt Repaid | 97.41% | 15.14% | 33.94% | 15.00% | -73.61% |
| Issuance of Common Stock | -100.00% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 8.69% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | 100.00% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 97.37% | -119.28% | 21.02% | 73.32% | -594.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 256.52% | 471.18% | -229.00% | -57.87% | 249.18% |